Aspartame

Aspartame is an artificial sweetener that is 150 to 200 times sweeter than sugar (sucrose). It is used in many so-called "diet" or sugar-free products. Aspartame is currently associated with a number of health risks: 

Aspartame and cancer

Aspartame has been classified as "possibly carcinogenic to humans" (Group 2B) by the International Agency for Research on Cancer (IARC) since July 2023, mainly based on suspected carcinogenicity in the liver. 

In particular, this IARC classification was established after the publication of a cohort study by the French National Institute of Health and Medical Research (INSERM) in 2022, which showed that aspartame consumption could be associated with an increased risk of cancer in humans. The highest risks involve breast cancer (up to +22% risk) and obesity-related cancers (up to +15% risk). The study also suggests that the consumption of sweeteners may be associated with an increased risk of cancer, similar to excessive sugar consumption. The scientists who conducted the study therefore "do not advise using artificial sweeteners as safe substitutes for sugar in foods and beverages." They also point out that the participants' aspartame consumption was below the acceptable daily intake (ADI). However, the research team conducting this cancer study highlights some uncertainties. Further studies are therefore required at this stage to confirm this correlation.

Previous studies conducted between 2010 and 2012 showed that aspartame consumption at the usual doses could increase the occurrence of non-Hodgkin's lymphoma (cancers of the lymphatic system) and myeloma (bone marrow cancers) in humans. Moreover, at very high doses, an increased incidence of liver cancer and lung cancer has been observed in male mice.

At the same time, many authorities consider that aspartame poses no health risks in the quantities consumed. In a report from June 2023, the JECFA (a joint FAO/WHO committee) stated that "there is no concern for carcinogenicity in animals from oral exposure to aspartame," confirming the safety of the ADI previously established in 1981. In 2013, the European Food Safety Authority (EFSA) concluded that "aspartame is not a health concern." However, these two assessments were published before the IARC report in July 2023, which provides new evidence of the carcinogenicity of aspartame. In the United States, the Food and Drug Administration (FDA) disagrees with the IARC's conclusions, declaring that "scientists do not have safety concerns when aspartame is used under the approved conditions."

Nevertheless, the protocol and industrial financing of several studies used by the authorities to reach their conclusions have been criticized for many years by various research groups. In 2016 and 2017, two different scientific journals showed that the funding of sweetener studies by the food industry may lead to biased results. Researchers in studies funded by the food industry could be more likely to conclude that sweeteners have no negative effects (particularly on weight) than those in independent studies.

Moreover, scientists from the French Health & Environment Network (RES), an NGO dedicated to promoting public health, denounced back in 2013 that "several members of the EFSA have a conflict of interest, in particular due to their work for the International Life Sciences Institute (ILSI), which lobbies for the food industry." Similarly, a scientific review published in July 2019 by two researchers at the University of Sussex in the United Kingdom also challenged the EFSA's position. The authors pointed out that the EFSA excluded 73 studies demonstrating the harmful effects of aspartame from its findings, while most of the studies showing insufficient evidence were included in the analysis. According to these researchers, the majority of the 73 excluded studies were more reliable than those that found no risks. The authors suggested that the EFSA may have been influenced by commercial conflicts of interest. They therefore called for an independent re-evaluation to be conducted in Europe.

Aspartame and diabetes

In 2023, an INSERM cohort study showed that aspartame increases the risk of developing type 2 diabetes by 48 to 63%. According to other studies, sweeteners may affect the intestinal flora and lead to metabolic disorders, particularly glucose intolerance (a common precursor to type 2 diabetes).

Aspartame and cardiovascular disease 

A 2022 cohort study by the INSERM showed that the consumption of aspartame could be associated with an increased risk of cardiovascular disease and more specifically cerebrovascular disease (+17% risk).

Aspartame and its effect on weight

In 2015, the French Agency for Food, Environmental, and Occupational Health & Safety (ANSES) found that "the data is insufficient to rule on a nutritional benefit" associated with the consumption of intense sweeteners. Its work showed that intense sweeteners played no part (positive or negative) in controlling weight.

A scientific review of several studies published in 2017 goes even further, concluding that sweeteners could be "associated with an increase in waist circumference" and "a higher incidence of abdominal obesity and excess weight" over the long term.

Sources:

ANSES (2015). Avis du 19 novembre 2014 révisé le 9 janvier 2015 relatif à l’évaluation des bénéfices et des risques nutritionnels des édulcorants intenses. Saisine n°2011-SA-0161. https://www.anses.fr/fr/system/files/NUT2011sa0161Ra.pdf

ANSES (2013). Avis de l'Anses en réponse à la consultation de l'Autorité Européenne de sécurité des aliments sur son projet d'avis concernant la réévaluation de l'aspartame (E951) en tant qu'additif alimentaire. Saisine n° 2013-SA-0016. https://www.anses.fr/fr/system/files/ERCA2013sa0016.pdf

EFSA (2013). Scientific Opinion on the re-evaluation of aspartame (E 951) as a food additive. EFSA Journal 2013;11(12):3496. https://www.efsa.europa.eu/fr/efsajournal/pub/3496

Food and Drug Administration (2023). Aspartame and Other Sweeteners in Food. https://www.fda.gov/food/food-additives-petitions/aspartame-and-other-sweeteners-food

Food Standard Australia and New Zealand (2024). Intense sweeteners. https://www.foodstandards.gov.au/consumer/additives/Sweeteners

Governement of Canada (2024). Aspartame. https://www.canada.ca/en/health-canada/services/food-nutrition/food-safety/food-additives/sugar-substitutes/aspartame-artificial-sweeteners.html

IARC (2024). Aspartame, Methyleugenol, and Isoeugenol. IARC Monographs on the Identification of Carcinogenic Hazards to Humans Volume 134. https://publications.iarc.who.int/627

The Association of UK Dietitians (2019). Policy Statement. The Use of Artificial Sweeteners. https://www.bda.uk.com/static/11ea5867-96eb-43df-b61f2cbe9673530d/policystatementsweetners.pdf

WHO / FAO (2023). Ninety-sixth report of the Joint FAO/WHO Expert Committee on Food Additives. https://iris.who.int/bitstream/handle/10665/376279/9789240083059-eng.pdf?sequence=1

WHO (2022). Health effects of the use of non-sugar sweeteners: a systematic review and meta-analysis. https://www.who.int/publications/i/item/9789240046429

European Food Industry Autority (2011). EU food additive experts fail to declare links with food industry. https://www.corporateeurope.org/en/efsa/2011/09/eu-food-additive-experts-fail-declare-links-food-industry

Debras C., Deschasaux-Tanguy M., Chazelas E, Sellem L., Druesne-Pecollo N., Esseddik Y., Szabo de Edelenyi F., Agaësse C., De Sa A., Lutchia R., Julia C., Kesse-Guyot E., Allès B., Galan P., Hercberg S., Huybrechts I., Cosson E., Tatulashvili S., Srour B., Touvier M., (2023). Artificial Sweeteners and Risk of Type 2 Diabetes in the Prospective NutriNet-Santé Cohort. Diabetes Care. 2023 Sep 1;46(9):1681-1690. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10465821

Gnudi, F., Panzacchi, S., Tibaldi, E., Iuliani, M., Sgargi, D., Bua, L. and Mandrioli, D., (2023) ‘Hemolymphoreticular Neoplasias from the Ramazzini Institute Long-term Mice and Rat Studies on Aspartame’, Annals of Global Health, 89(1), p. 43. Available at: https://doi.org/10.5334/aogh.4163.

Debras C., Chazelas E., Sellem L., Porcher R., Druesne-Pecollo N., Esseddik Y. et al., (2022). Artificial sweeteners and risk of cardiovascular diseases: results from the prospective NutriNet-Santé cohort BMJ 2022; 378 :e071204. https://doi.org/10.1136/bmj-2022-071204

Debras C., Chazelas E., Srour B., Druesne-Pecollo N., Esseddik Y., Szabo de Edelenyi F., Agaësse C., De Sa A., Lutchia R., Gigandet S., Huybrechts I., Julia C., Kesse-Guyot E., Allès B., Andreeva VA., Galan P., Hercberg S., Deschasaux-Tanguy M., Touvier M., (2022). Artificial sweeteners and cancer risk: Results from the NutriNet-Santé population-based cohort study. PLoS Med. 2022 Mar 24;19(3):e1003950. https://doi.org/10.1371/journal.pmed.1003950

Suez, J., Cohen, Y., Valdés-Mas, R., Mor, U., Dori-Bachash, M., Federici, S., … & Elinav, E., (2022). Personalized microbiome-driven effects of non-nutritive sweeteners on human glucose tolerance. Cell, 185(18), 3307-3328.

Wang, W., Nettleton, J. E., Gänzle, M. G., & Reimer, R. A., (2022). A metagenomics investigation of intergenerational effects of non-nutritive sweeteners on gut microbiome. Frontiers in nutrition, 1236. https://doi.org/10.3389/fnut.2021.795848

Çadirci, K., Tozlu, Ö. Ö., Türkez, H., & Mardinoğlu, A., (2020). The in vitro cytotoxic, genotoxic, and oxidative damage potentials of the oral artificialsweetener aspartame on cultured human blood cells. Turkish Journal of Medical Sciences, 50(2), 448-454.

Gerasimidis, K., Bryden, K., Chen, X., Papachristou, E., Verney, A., Roig, M., … & Parrett, A., (2020). The impact of food additives, artificial sweeteners and domestic hygiene products on the human gut microbiome and its fibre fermentation capacity. European journal of nutrition, 59(7), 3213-3230. https://doi.org/10.1007/s00394-019-02161-8

Mandrioli D., Kearns CE., Bero LA., (2020). Relationship between Research Outcomes and Risk of Bias, Study Sponsorship, and Author Financial Conflicts of Interest in Reviews of the Effects of Artificially Sweetened Beverages on Weight Outcomes: A Systematic Review of Reviews. PLoS One. 2016 Sep 8;11(9):e0162198. doi: 10.1371/journal.pone.0162198. Erratum in: PLoS One. 2020 Mar 10;15(3):e0230469. doi: 10.1371/journal.pone.0230469. PMID: 27606602; PMCID: PMC5015869. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5015869/

Millstone EP., Dawson E., (2019). EFSA’s toxicological assessment of aspartame : was it even-handedly trying to identify possible unreliable positives and unreliable negatives ? Arch Public Health. 2019 Jul 15 ;77 :34.

Toews I., Lohner S., Küllenberg de Gaudry D., Sommer H., Meerpohl JJ., (2019). Association between intake of non-sugar sweeteners and health outcomes: systematic review and meta-analyses of randomised and non-randomised controlled trials and observational studies. BMJ. 2019 Jan 2;364:k4718. doi: 10.1136/bmj.k4718. Erratum in: BMJ. 2019 Jan 15;364:l156. doi: 10.1136/bmj.l156. PMID: 30602577; PMCID: PMC6313893. https://pubmed.ncbi.nlm.nih.gov/30602577/

Litman EA., Gortmaker SL., Ebbeling CB., Ludwig DS., (2018). Source of bias in sugar-sweetened beverage research: a systematic review. Public Health Nutr. 2018 Aug;21(12):2345-2350. doi: 10.1017/S1368980018000575. Epub 2018 Mar 26. PMID: 29576024; PMCID: PMC6063770. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6063770/

Azad MB., Abou-Setta AM., Chauhan BF., Rabbani R., Lys J, Copstein L., Mann A., Jeyaraman MM., Reid AE., Fiander M., MacKay DS., McGavock J., Wicklow B., Zarychanski R., (2017). Nonnutritive sweeteners and cardiometabolic health: a systematic review and meta-analysis of randomized controlled trials and prospective cohort studies. CMAJ. 2017 Jul 17;189(28):E929-E939. doi: 10.1503/cmaj.161390. PMID: 28716847; PMCID: PMC5515645.

Stepien M., Duarte-Salles T., Fedirko V., Trichopoulou A., Lagiou P., Bamia C. et al., (2016). Consumption of soft drinks and juices and risk of liver and biliary tract cancers in a European cohort. Eur J Nutr. 2016;55(1):7–20. doi:10.1007/s00394-014-0818-5.

Soffritti et al., (2014). The carcinogenic effects of aspartame : The urgent need for regulatory re-evaluation. Am J Ind Med. 57. 10.1002/ajim.22296.

Suez et al., (2014). Artificial sweeteners induce glucose intolerance by altering the gut microbiota. Nature. 70. 10.1038/nature13793.

Maira Bes-Rastrollo, Matthias B. Schulze, Miguel Ruiz-Canela, Miguel A. Martinez-Gonzalez (2013). Financial Conflicts of Interest and Reporting Bias Regarding the Association between Sugar-Sweetened Beverages and Weight Gain: A Systematic Review of Systematic Reviews. https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1001578

Réseau Environnement Santé (2013). Communiqué de presse. Aspartame : l’avis de l’EFSA enfreint les règles de la déontologie de l’expertise et rejette les données scientifiques récentes (cancer, prématurité, troubles cognitifs, effets métaboliques). https://www.reseau-environnement-sante.fr/communique-de-presse-18-fevrier-2013-aspartame-lavis-de-lefsa-enfreint-les-regles-de-la-deontologie-de-lexpertise-et-rejette-les-donnees-scientifiques-recentes/

Soffritti et al., (2010). Aspartame administered in feed, beginning prenatally through life span, induces cancers of the liver and lung in male Swiss mice. American Journal of Industrial Medicine, 53(12), 1197-1206.

Koehler SM., Glaros A., (1988). The effect of aspartame on migraine headache. Headache. 1988 Feb ;28(1) :10-4.

How did we do?